Etorikoksib JGL, a novelty in the prescription portfolio

JGL’s prescription portfolio has been expanded with an analgesic from the "Anti-inflammatory and antirheumatic products” pharmacotherapeutic group, with the brand name:

Etorikoksib JGL 60 mg film-coated tablets

Etorikoksib JGL 90 mg film-coated tablets


14x60 mg, 14x90 mg

The product is indicated in adults and adolescents over the age of 16 for alleviating symptoms of chronic and acute pain in the following approved indications: osteoarthitis, rheumatoid arthritis and ankylosing spondylitis, pain and signs of inflammation related to acute uric arthritis (gout), and shortterm treatment of pain following a dental surgery procedure. Etorikoksib JGL is included in the CIHI supplemental list of drugs.

To make this website run properly and to improve your experience, we use cookies. For more detailed information, please check our Privacy and personal data protection.

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.